Centile Bioscience Inc.

SaaS & Software Bethesda, MD

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
SaaS & Software
Headquarters
Bethesda, MD
Street
5023 Wissioming Rd.
Zip
20816

Offering

Total offering
$4.1M
Amount sold
$3.1M
First sale
Mar 20, 2026
Min investment
$0
Securities
Equity, Other
Federal exemption
Rule 506(b)
Investors so far
3

How this filing compares

Ranked #106 of 244 SaaS & Software filings in April 2026 by offering amount.

Median SaaS & Software filing in April 2026: $4M. This offering is 1.0× the median.

Other Maryland filings this week: STANDARD VALUE LP, StepStone VC Secondaries Fund VII (Cayman) LP, StepStone VC Secondaries Fund VII LP, StepStone VC Secondaries Fund VII ND (Cayman) LP, StepStone VC Secondaries Fund VII ND LP

Leadership

Jakob Seidlitz — Executive Officer (also: Director)

Richard Bethlehem — Executive Officer

Joshua Bernstock — Executive Officer (also: Director)

L. Keith Mullins — Director

Hannah Mamuszka — Director

Filing details

Centile Bioscience Inc. filed a Form D with the SEC on April 16, 2026.

Other newest SaaS & Software companies

Other newest companies in Maryland